MedTrace Logo

Spinocerebellar Ataxia Type 27B Natural History Study (SCA27B-NHS)

NCT06472557 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-04-06

No results posted yet for this study

Summary

This international, multi-center, multi-modal, and prospective observational cohort study aims to validate trial outcomes for capturing disease progression in Spinocerebellar Ataxia Type 27B (SCA27B), with combined multi-modal capture of clinical outcome assessments, digital-motor assessments, and molecular biomarkers.

Conditions

  • Spinocerebellar Ataxia Type 27B

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Matthis Synofzik, Prof. Dr. · University Hospital Tübingen

  • Andreas Traschütz, Dr. Dr. · University Hospital Tübingen

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-04
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Czechia
  • Germany
  • Italy
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06472557 on ClinicalTrials.gov